Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Central Garden & Pet Co Class A
CENTA
$2.39B
| $4.24M | 0.01% |
+329,221
| New | +$3.33M |
|
|
BRCM
1427
DELISTED
BROADCOM CORP CL-A
BRCM
| $4.24M | 0.01% |
82,499
-969,728
| -92% | -$49.9M |
|
|
RPTP
1428
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $4.24M | 0.01% |
700,024
-80,175
| -10% | -$982K |
|
|
ACET
1429
DELISTED
Aceto Corp
ACET
| $4.23M | 0.01% |
154,207
+141,667
| +1,130% | +$3.53M |
|
|
SFR
1430
DELISTED
Starwood Waypoint Homes
SFR
| $4.23M | 0.01% |
177,570
+84,514
| +91% | +$2.07M |
|
1431
Alkermes
ALKS
$8.26B
| $4.23M | 0.01% |
72,026
-150,761
| -68% | -$9.95M |
|
|
STR
1432
DELISTED
QUESTAR CORP
STR
| $4.21M | 0.01% |
217,113
+107,004
| +97% | +$2.18M |
|
1433
iShares MSCI Brazil ETF
EWZ
$8.23B
| $4.21M | 0.01% |
191,813
+131,713
| +219% | +$3.51M |
|
1434
Virtu Financial
VIRT
$5.76B
| $4.21M | 0.01% |
+183,631
| New | +$4.21M |
|
|
DVAX
1435
DELISTED
Dynavax Technologies
DVAX
| $4.2M | 0.01% |
171,116
+156,781
| +1,094% | +$4.44M |
|
|
SCMP
1436
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $4.2M | 0.01% |
211,341
-280,642
| -57% | -$6.43M |
|
|
FEIC
1437
DELISTED
FEI COMPANY
FEIC
| $4.19M | 0.01% |
57,372
+31,798
| +124% | +$2.51M |
|
1438
MidCap Financial Investment
MFIC
$797M
| $4.17M | 0.01% |
253,891
+63,181
| +33% | +$1.25M |
|
1439
Invesco Golden Dragon China ETF
PGJ
$92.2M
| $4.16M | 0.01% |
+161,949
| New | +$4.61M |
|
1440
Chunghwa Telecom
CHT
$33.5B
| $4.14M | 0.01% |
+137,147
| New | +$4.19M |
|
1441
Rigel Pharmaceuticals
RIGL
$873M
| $4.14M | 0.01% |
167,744
-7,921
| -5% | -$236K |
|
|
NPKI
1442
NPK International
NPKI
$1.12B
| $4.14M | 0.01% |
808,967
-901,810
| -53% | -$6.17M |
|
1443
Pultegroup
PHM
$24.9B
| $4.13M | 0.01% |
+218,863
| New | +$4.45M |
|
1444
Tonix Pharmaceuticals
TNXP
$234M
| – | – |
0
| – | – |
|
1445
Chemed
CHE
$7.11B
| $4.12M | 0.01% |
+30,891
| New | +$4.32M |
|
1446
Compass Minerals
CMP
$1.03B
| $4.12M | 0.01% |
52,589
-80,766
| -61% | -$6.63M |
|
|
ANAT
1447
DELISTED
American National Group, Inc. Common Stock
ANAT
| $4.12M | 0.01% |
42,165
+7,403
| +21% | +$761K |
|
|
ININ
1448
DELISTED
Interactive Intelligence Group, inc.
ININ
| $4.12M | 0.01% |
138,588
+123,631
| +827% | +$4.72M |
|
|
UNTD
1449
DELISTED
UNITED ONLINE INC COM NEW
UNTD
| $4.11M | 0.01% |
411,015
+156,454
| +61% | +$1.98M |
|
1450
CALL
Macy's
M
$5.94B
| $4.11M | 0.01% |
+80,000
| New | +$5.02M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.